A Relative Bioavailability Study of Alprazolam 3 mg Extended Release Tablets Under Non-Fasting Conditions

This study has been completed.

Study NCT00865657 Information provided by Actavis Inc.

First Received: March 18, 2009 No Changes Posted

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	September 2005
Primary Completion Date:	September 2005 (Final data collection date for primary outcome measure)